Longevity Startups

Humanaut provides regenerative medicine, sexual health, and advanced therapies through clinician-led care that emphasizes transparency and patient empowerment. The company serves individuals seeking precision medicine with ethical pricing and a focus on long-term wellness outcomes.

1 investor

A dietary supplement brand offering marine collagen capsules designed to improve skin hydration, elasticity, and reduce visible signs of aging. The product targets women seeking beauty and wellness solutions through scientifically-tested collagen peptides.

1 investor

Hummsa Biotech develops oral small molecule therapeutics targeting chronic metabolic diseases through multi-targeted approaches, aiming to shift treatment from reactive to preventive and regenerative care. The company prioritizes affordability and accessibility across global markets.

1 investor

Imagene Labs provides a cloud-based genetic analytics platform for healthcare services and wellness brands that delivers personalized product recommendations based on customers' DNA analysis using ethnically-relevant reference datasets. The platform covers traits including aging, fitness, nutrition, skin health, and children's health, and is compliant with Singapore's data protection standards.

1 investor

Immortals offers a longevity protocol based on Bryan Johnson's Blueprint approach, letting consumers follow his measured biomarker and supplement regimen. It sells health and longevity products such as supplement mixes and capsules aimed at people seeking to improve their health and slow aging.

1 investor

Immunique is a science-based biotech company developing cell therapies that restore balance in the immune system to treat disease and support long-term patient recovery. Its research focuses on immune cell function and is aimed at extending healthy lifespan through clinical- and data-driven treatment strategies.

1 investor

Immunocodex develops lipid nanoparticle mRNA-based therapies targeting dendritic cells to induce immune tolerance for the treatment of autoimmune diseases. The company employs a precision approach that aims to re-program immune cells to suppress inflammatory responses while avoiding broad immunosuppression.

1 investor

Instalab provides comprehensive health testing, physician consultations, and personalized health protocols designed for busy founders and entrepreneurs. The service combines biomarker analysis with lifestyle optimization to improve daily performance and support longevity while fitting into demanding startup schedules.

1 investor

Isaac Health is a tech-enabled platform and telehealth service that helps health plans and systems identify and manage brain health and dementia conditions across patient populations. The company combines behavioral neurology expertise with digital health tools to address population-level brain health management.

1 investor

锦欣康养 is a subsidiary of Jinxin Medical Group that operates elderly care services combining medical treatment and senior living, including institutional care, home and community care, geriatric medicine, rehabilitation, and nursing. It runs care facilities and senior apartments across the Chengdu-Chongqing region, the Yangtze River Delta, and the Greater Bay Area in China.

1 investor

A Chinese health management and online medical services company (Ping An Good Doctor / Ping An Health) offering integrated financial-health services, corporate health management, and consumer healthcare including medical appointment assistance and longevity management services. It serves enterprise clients and individual consumers across China.

1 investor

Jocasta Neuroscience is a biotechnology company developing JN-0413, a proprietary subcutaneous formulation of soluble α-Klotho protein aimed at treating age-related cognitive decline and neurodegenerative diseases such as mild cognitive impairment, Alzheimer's, and Parkinson's-related dementia. The company targets brain aging at its root cause and anticipates beginning human trials in early 2027.

1 investor

Zero offers Lucis, a preventive health service that uses accredited laboratory blood tests to measure key biomarkers, benchmark results against scientific literature, and provide personalized lifestyle guidance that users can discuss with their doctor. It serves individuals focused on prevention and longevity, drawing on a network of over 450 accredited laboratories in Europe.

1 investor

Junevity is a biotech company developing siRNA therapeutics based on its RESET platform, which uses transcription factor repression to restore healthy gene expression and target age-related diseases. The company applies bioinformatics, machine learning, and cellular aging research to develop treatments for metabolism and aging-related conditions.

1 investor

Kadis Bio develops human induced pluripotent stem cell (hiPSC) therapies for treating cardiovascular disease, targeting peripheral arterial disease and critical limb ischemia. Its approach aims to promote blood vessel growth for conditions such as ischemic heart disease, diabetic retinopathy and neuropathy, and wound healing.

1 investor

Kalohexis is a biopharmaceutical company developing treatments that target the melanocortin system, the body's regulator of metabolic homeostasis, to address metabolic disorders beginning with obesity and cancer cachexia. Its therapies aim to adjust the body's metabolic set-point for patients with metabolic disease.

1 investor

Karydo TherapeutiX is a Japanese therapeutics company operating in the biotech and drug discovery space. The page presents its corporate governance and scientific leadership without further detail on its products.

1 investor

Kithward operates a platform that helps people find and evaluate Independent Living and senior living communities that fit their needs and budget. For provider communities, it offers a partner program that delivers qualified, better-informed leads and a channel to advertise their offerings.

1 investor

Klotho Therapeutics is a biotech company developing protein-based therapeutics that mimic the natural human Klotho protein to address age-related diseases including cognitive decline, kidney disease, diabetes, and cancer. The company focuses on longevity treatment and aims to enter human trials within two years targeting kidney disease.

1 investor

Leucadia Therapeutics is developing Arethusta, a first-in-class outpatient treatment for Alzheimer's disease, initially aiming to reverse mild cognitive impairment associated with the condition before targeting prevention and cure. The company operates in the biotech and neurological therapeutics space.

1 investor

L'évive Labs develops longevity supplements and biomarker-based testing (DNA, epigenetics, blood work, and wearable integration) paired with doctor-led programs and a community focused on healthy aging. It targets health-conscious consumers and biohackers interested in slowing biological aging.

1 investor

LifeCellsNI provides cord blood and stem cell extraction and cryogenic storage services for individuals and families, alongside laboratory rentals with GMP-grade processing for researchers, biotech companies, and clinical trials. It operates a biobanking facility serving Northern Ireland and Ireland.

1 investor

Lifespan Research Institute invests in biotechnology startups developing regenerative medicine and longevity therapies. The institute funds companies working on age-related disease treatment, including cellular senescence, tissue damage repair, and cancer therapeutics.

1 investor

LiST provides an AI platform for medical underwriting and longevity risk assessment, enabling insurance and financial services partners to make data-driven decisions through natural language processing and automated pricing.

1 investor